Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RTI/Exactech

This article was originally published in The Gray Sheet

Executive Summary

Optimal distribution method for Regeneration Technologies, Inc.'s Regenaform "moldable" maxillofacial bone paste is the only remaining item to be resolved after the companies work out a distribution agreement, effective Aug. 30. Exactech will serve as exclusive worldwide distributor for RTI-processed bone paste products for non-spinal musculoskeletal orthopedic procedures. The companies also will co-develop new bone paste products. The RTI/Exactech agreement is part of a settlement related to a 2001 arbitration ruling (1"The Gray Sheet" Jan. 7, 2002, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel